Publications

January 2020
Case

Terra Nova: A Social Business Trying to Unlock Land Rights for the Urban Poor in Brazil

By: Julie Battilana, Ruth Costas, Marissa Kimsey and Priscilla Zogbi

Brothers André and Daniel Albuquerque founded the company Terra Nova in 2001 to mediate land disputes between poor families illegally living in urban areas and the official landowners—with the aspiration to improve the lives of the poor. A business-led approach to the... View Details

Keywords: Mission and Purpose; Social Enterprise; Entrepreneurship; Negotiation; Power and Influence; Social Issues; Conflict and Resolution; Business and Government Relations; Infrastructure; Urban Development; Real Estate Industry; Brazil; Latin America

28 Aug 2018
First Look

New Research and Ideas, August 28, 2018

Cai, Wei, Susanna Gallani, and Jee-Eun Shin Abstract— Organizations often struggle with motivating employees to develop innovative ideas that may benefit the firm, especially when the standard tasks for which employees are measured and... View Details

Keywords: Dina Gerdeman

March 2025
Teaching Note

Seattle's Climate Pledge Arena: Ticket to a Greener Future

By: Rosabeth Moss Kanter and Jacob A. Small

Teaching Note for HBS Case No. 325-110. CEO Tim Leiweke reviewed the process by which his newly formed Oak View Group had managed a major rebuild of a landmark arena in Seattle which attracted a National Hockey League franchise and major entertainers concerned about... View Details

Keywords: Climate Change; Environmental Sustainability; Leadership; Bids and Bidding; Standards; Corporate Social Responsibility and Impact; Green Buildings; Construction; Partners and Partnerships; Sports Industry; Entertainment and Recreation Industry; Seattle

August 2024 (Revised February 2025)
Case

Novo Nordisk Foundation

By: Debora L. Spar and Julia M. Comeau

In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details

Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Profit; Corporate Governance; Business or Company Management; Corporate Social Responsibility and Impact; Expansion; Philanthropy and Charitable Giving; Nonprofit Organizations; Pharmaceutical Industry; Denmark; Europe

2012
Working Paper

'Power from Sunshine': A Business History of Solar Energy

By: Geoffrey Jones and Loubna Bouamane

This working paper provides a longitudinal perspective on the business history of solar energy between the nineteenth century and the present day. It covers early attempts to develop solar energy, the use of passive solar in architecture before World War 2, and the... View Details

Keywords: Renewable Energy; Business History; Policy; Entrepreneurship; Innovation and Invention; Business Model; Energy Industry

Read Now

02 Aug 2022
Research & Ideas

6 Strategies for Building Socially Responsible—and Profitable—Companies

A dozen years ago, Harvard Business School Professor George Serafeim wondered why some companies operated with an eye toward the greater good, while most did not. Back then, he always got the same response: Corporate leaders thought social and environmental practices... View Details

Keywords: by Lane Lambert

May 2016
Background Note

Health Systems in the Developing World

By: Kevin Schulman, Muhammed Pate and Gary Carbell

This note offers an approach to the evaluation of health care markets globally. It prepares students with a set of questions about the organization of core elements of the health care system. The organization of these elements can vary across markets and can vary in... View Details

Keywords: Health Care and Treatment; Developing Countries and Economies; Public Sector; Private Sector; Opportunities; Analysis

September 2022
Article

Find and Replace: R&D Investment Following the Erosion of Existing Products

By: Joshua L. Krieger, Xuelin Li and Richard T. Thakor

How do innovative firms react when existing products experience negative shocks? We explore this question with detailed project-level data from drug development firms. Using FDA Public Health Advisories as idiosyncratic negative shocks to approved drugs, we first... View Details

Keywords: R＆D Investments; Drug Development; Product Shocks; M＆A; Biopharmaceutical Industry; FDA; System Shocks; Research and Development; Investment; Decision Making; Pharmaceutical Industry

October 2018
Case

Corruption and Business in Emerging Markets

By: Geoffrey Jones, Tarun Khanna and Nataliya Langburd Wright

The case is built around video clips from top business leaders in emerging markets who were interviewed for Harvard Business School’s innovative Creating Emerging Markets oral history project. Corruption is a widespread problem in emerging markets, and this case is... View Details

Keywords: Crime and Corruption; Emerging Markets

June 2006
Case

Home Equity Protection

Nearly 70% of households in the United States own their own home and, yet, virtually no household is insured against a crash in housing values. Is there a market for an insurance product, home equity protection, that would provide this protection? Focuses on the... View Details

Keywords: Housing; Insurance; Product Design; Equity; Insurance Industry

Find at Harvard

2018
Book

High-Skilled Migration to the United States and Its Economic Consequences

By: Gordon H. Hanson, William R. Kerr and Sarah Turner

Immigration policy is one of the most contentious public policy issues in the United States today. High-skilled immigrants represent an increasing share of the U.S. workforce, particularly in science and engineering fields. These immigrants affect economic growth,... View Details

Keywords: Immigration; Policy; Economics; Outcome or Result; United States

Find at Harvard

23 Jun 2009
First Look

First Look: June 23

Principles that Matter: Sustaining Software Innovation from the Client to the Web Author:Marco Iansiti Abstract Economic analysis often reviews the role of principles—such as respect for intellectual property rights—in driving innovation.... View Details

Keywords: Martha Lagace

January 2017 (Revised August 2017)
Case

Weathernews

By: Karim R. Lakhani and Akiko Kanno

Tomohiro Ishibashi (Bashi), chief executive officer for B to S, and Julia Foote LeStage, chief innovation officer of Weathernews Inc., were addressing a panel at the HBS Digital Summit on creative uses of big data. They told the summit attendees about how the Sakura... View Details

Keywords: Crowdsourcing; Operations; Globalization; Weather; Forecasting and Prediction; Global Strategy

07 Feb 2017
First Look

First Look at New Research: February 7

Reinsurance developed at the fringe of financial services and, for most of its existence, was largely unnoticed outside the expert community. However more recently public and professional sensitivity towards managing risks has increased.... View Details

Keywords: Sean Silverthorne

September 2024
Article

Standing on the Shoulders of Science

By: Joshua Lev Krieger, Monika Schnitzer and Martin Watzinger

Today’s innovations rely on scientific discoveries of the past, yet only some corporate R&D builds directly on scientific output. In this paper, we analyze U.S. patents to investigate how firms generate value by building on prior art “closer” to science. We show... View Details

Keywords: Patent Novelty; Value Capture; Science; Patents; Valuation; Research and Development

Read Now

2021
Chapter

Digital Infrastructure

By: Shane Greenstein

What determines the supply of innovative digital infrastructure and how does variance in supply shape the performance of digital services? The essay reviews research into the economic impact of deployment, innovation, and adoption of digital infrastructure. It... View Details

Keywords: Information Technology; Infrastructure; Economics; Policy; Research; Analysis; United States

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry